Hubei Goto Biopharm Co.,Ltd. (SHE:300966)
China · Delayed Price · Currency is CNY 27.44
-1.16 (-4.06%)
May 12, 2026, 3:04 PM CST
Hubei Goto Biopharm Market Cap
Hubei Goto Biopharm has a market cap or net worth of 3.16 billion as of May 12, 2026. Its market cap has increased by 85.59% in one year.
Market Cap
3.16B
Enterprise Value
4.48B
Revenue
628.90M
Ranking
n/a
PE Ratio
n/a
Stock Price
27.44
Market Cap Chart
Since April 9, 2021, Hubei Goto Biopharm's market cap has decreased from 6.57B to 3.16B, a decrease of -51.93%. That is a compound annual growth rate of -13.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 3.29B | 45.25% |
| Dec 31, 2025 | 2.27B | 21.86% |
| Dec 31, 2024 | 1.86B | -29.78% |
| Dec 29, 2023 | 2.65B | -14.93% |
| Dec 30, 2022 | 3.11B | -34.18% |
| Dec 31, 2021 | 4.73B | -28.02% |
| Apr 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition